Cibus, Inc. (CBUS) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Cibus, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBUS
Cibus, Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — CBUS vs LUCD
growth of $100 · dividends reinvested · last 5yCBUS -98.9% (-59.2%/yr)LUCD -95.0% (-45.0%/yr)LUCD compounded faster over this window
CBUS LUCD
CBUS vs LUCD: by the numbers
- •CBUS is the larger company ($122M vs $114M market cap).
- •Both run net losses; LUCD's is the smaller (-959.76% vs -2258.89% net margin).
Metrics side by side
Valuation
| Metric | CBUS | LUCD |
|---|---|---|
| P/S ratio | 28.10 | 20.99 |
| P/B ratio | 8.25 | 10.46 |
Profitability
| Metric | CBUS | LUCD |
|---|---|---|
| Gross margin | -62.76% | -60.26% |
| Operating margin | -1853.92% | -1054.82% |
| Net margin | -2258.89% | -959.76% |
| ROE | -663.38% | -478.26% |
| ROIC | -17.99% | -145.10% |
Growth (annualized)
| Metric | CBUS | LUCD |
|---|---|---|
| Revenue CAGR (5Y) | -34.28% | N/A |
| Total return CAGR (5Y) | -59.70% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.